Activated Charcoal for sure!

http://www.testfoundation.org/hgtoxicity.htm

http://www.testfoundation.org/amalgampage.htm

http://www.amalgam.org

http://www.relfe.com/mercury.html

http://www.law.stanford.edu/library/special/B147727.DOC

The State of California has classified mercury and mercury compounds
as reproductive toxins since July 1, 1990. (Cal. Code Regs., tit.
22, § 12000, subd. (c)(1), p. 182, col. 2.) "Mercury is a highly
toxic metal that is more dangerous than lead, cadmium and arsenic in
relation to its effect on the body." (Leading Edge Research Group,
Mercury Amalgam: Contamination of Human Neurophysiology (1996)

The clinical presentation of mercury toxicity can manifest in a
variety of ways depending on the nature of the exposure, the
intensity of the exposure, and the chemical form. Acute toxicity
usually is related to the inhalation of elemental or ingestion of
inorganic mercury.

Acute exposure due to inhaled elemental mercury can lead to
pulmonary symptoms. Initial signs and symptoms, such as fever,
chills, shortness of breath, metallic taste, and pleuritic chest
pain, may be confused with metal fume fever. Other possible symptoms
could include stomatitis, lethargy, confusion, and vomiting.

Recovery is usually without sequela, but pulmonary complications of
inhaled toxicity may include interstitial emphysema, pneumatocele,
pneumothorax, pneumomediastinum, and interstitial fibrosis. Fatal
ARDS has been reported following elemental mercury inhalation.

Chronic and intense acute exposure causes cutaneous and neurological
symptoms. The classic triad found in chronic toxicity is tremors,
gingivitis, and erethism (ie, a constellation of neuropsychiatric
findings that includes insomnia, shyness, memory loss, emotional
instability, depression, anorexia, vasomotor disturbance,
uncontrolled perspiration and blushing).

Additional findings may include headache, visual disturbance (eg,
tunnel vision), peripheral neuropathy, salivation, insomnia, and
ataxia.

Without a complete history, mercury toxicity, especially in the
elderly, can be misdiagnosed as Parkinson's disease, senile dementia,
metabolic encephalopathy, depression, or Alzheimer's disease.

Elemental mercury has poor GI absorption and, therefore, oral or
rectal exposure to elemental mercury from a thermometer should have
no toxic effect. Dental amalgams also contain elemental mercury.
Dental professionals who are in contact with amalgam must follow
specific guidelines in order not to be exposed to toxic amounts of
aerosolized elemental mercury. Patients with dental amalgam fillings
have slightly elevated levels in their urine, but these findings have
not correlated with any systemic disease.

Inorganic mercury or mercuric salt exposure mainly occurs through
the oral and GI tract. Its corrosive properties account for the
majority of the acute signs and symptoms. The acute presentation can
include ashen-gray mucous membranes secondary to precipitation of
mercuric salts, hematochezia, vomiting, severe abdominal pain, and
hypovolemic shock. Systemic effects usually begin several hours after
ingestion and may last several days. These effects include metallic
taste, stomatitis, gingival irritation, foul breath, loosening of
teeth, and renal tubular necrosis leading to oliguria or anuria.

Acute Respiratory Distress Syndrome
Amyotrophic Lateral Sclerosis
Dermatitis, Exfoliative
Disk Battery Ingestion
Gastroenteritis
Myasthenia Gravis
Pediatrics, Bronchiolitis
Pediatrics, Fifth Disease or Erythema Infectiosum
Renal Failure, Acute
Toxicity, Arsenic
Toxicity, Carbon Monoxide
Toxicity, Iron
Toxicity, Phenytoin
Toxicity, Theophylline

Other Problems to be Considered:

Elemental mercury toxicity
Adverse effects of therapeutic medication (eg, lithium, theophylline,
phenytoin)
Alzheimer's disease
Cerebellar degenerative disease or tumor
Delayed neuropsychiatric sequela of carbon monoxide poisoning
Ethanol or sedative hypnotic drug withdrawal
Lacunar infarction
Metabolic encephalopathy
Parkinson's disease
Senile dementia

Inorganic mercury toxicity (mercury salts)
Acid ingestion
Alkali ingestion
Arsenic toxicity
Iron toxicity
Phosphorus toxicity
Similar to the causes of acute gastroenteritis

Organic mercury toxicity
Cerebral palsy
Intrauterine hypoxia
Teratogenic effects in the embryo



Acrodynia, known as pink disease and is considered to be a mercury
allergy, presents with erythema of the palms and soles, edema of the
hands and feet, desquamating skin rash, hair loss, pruritus,
diaphoresis, tachycardia, hypertension, photophobia, irritability,
anorexia, insomnia, poor muscle tone, constipation, or diarrhea.

Acrodynia does not present in everyone who is exposed to inorganic
mercury, but is an indicator of widespread disease.


Mercury (Elemental) Fever, chills, gastrointestinal complaints,
pulmonary edema, encephalopathy. Affinity for SH-groups and other
compounds inhibiting wide variety of enzyme and transport mechanisms.
Primarily lungs.

Mercury (Inorganic) Stomatitis, sore throat, nausea, vomiting,
abdominal pain, hematemesis, renal failure, shock. Gastrointestinal
tract, lungs and skin.

Mercury (Organic) Depending on complex, may mimic inorganic poisoning
or possibly dysarthria, visual field deficits and encephalopathy.
Primarily gastrointestinal tract and lungs.


http://www.state.hi.us/health/eh/heer/poison.html

http://www.amalgam.org

http://hometown.aol.com/andycutler

http://www.cfspages.com

http://www.melisa.org

http://www.bioprobe.com

http://www.toxicteeth.net

The following is an abstract of a paper presented
by RAYMOND SINGER, PH.D.: Singer, R. (1995).

Neuropsychological assessment of a practicing dentist with elevated
urinary mercury.
Fundamental and Applied Toxicology, Supplement:
The Toxicologist, 15, 1, March, 1995.

Website:

http://www.neurotox.com

NEUROPSYCHOLOGICAL ASSESSMENT OF A PRACTICINGm DENTIST WITH ELEVATED
URINARY MERCURY.

R. Singer. Santa Fe,
New Mexico,
USA

Dentists are exposed to mercury from amalgam (composed of 52%
mercury, 8% copper, 37% silver)
used as implants for dental restoration. A recent study of 32% of
Singapore's dentists found mercury
dose-related neuropsychological deficits when compared with controls.

The current subject, a dentist practicing for 14 years in the USA,
was referred by his physician for neurobehavioral examination.
The subject presented with symptoms including fatigue, GI problems,
sweats, tremors, rashes, bowel dyscontrol, and heart arrhythmia.
Tremors of the hand and eyelid affect the subject's hand stability
while working.

Results of the Neurotoxicity Screening Survey showed a profile of
symptoms consistent with neurotoxicity.
Urine sampling (24 h) over the past year found 2.1 - 99 ppb mercury,
averaging 35 ppb (expected range < 2 ppb; atomic fluorescence
spectrometry).
High readings may be related with chelation therapy.

Current IQ was at the 87% (% = percentile; 91-96% or greater
estimated pre-morbidly),
consistent with his presentation as an intelligent, competent
dentist.
In contrast to a relatively high IQ, appropriate neuropsychological
testing revealed that the subject
has deficits in immediate memory (16%);
visuospatial perception (50%);
visual memory; visual figure-ground perception (50%);
verbal learning (2-5%); mental flexibility (12%);
attentional processes (19%); logical memory (p < .004);
and non-verbal recognition memory (50%).

Neuropsychological testing helped confirm mercury toxicity affecting
multiple organ systems.

Such deficits impact the subject's ability to practice dentistry, and
raises questions as to effects of mercury in other dentists, as well
as possible subclinical or clinical effects among the estimated 80-
90% of Americans with mercury amalgam implants.

REMINDER:

The legal position of the American Dental Association (ADA) on the
safety of mercury containing dental amalgam and the use
of the material by dentists in the United States was recently stated
as follows:

"The ADA owes no legal duty of care to protect the public from
allegedly dangerous products used by dentists.

The ADA did not manufacture, design, supply or install the mercury-
containing amalgams. The ADA does not control those
who do. The ADA's only alleged involvement in the product was to
provide information regarding its use.

Dissemination of information relating to the practice of dentistry
does not create a duty of care to protect the public from
potential injury".

Source: Legal brief filed in 1995 by attorneys for the ADA in W.H.
Tolhurst vs. Johnson and Johnson Consumer Products, Inc.;
Engelhard Corporation; ABE Dental, Inc.; the American Dental
Association, et al., in the Superior Court of the State of California,
in and for the County of Santa Clara, CA, Case No. 718228.


CALGARY, CANADA--Researchers at the University of Calgary Medical
School will hold a press conference today to present the visual
evidence of Mercury's effect on growing nerve cells, another
correlation to Alzheimer's disease. These findings may influence the
future acceptance of mercury-containing vaccines and "mercury/silver
amalgam" dental fillings.

Utilizing digital time-lapse photography to display the damage to
nerve cells that minute amounts of mercury cause, researchers Leong,
Syed and Lorscheider experimented with mercury levels that are
similar to or below those levels of mercury found in the brains of
humans with "mercury/silver amalgam" dental fillings. Dr. Lorscheider
will speak at the press conference on the significance or their
research.

The peer-reviewed study published today in the prestigious journal
NeuroReports provides visual documentation of the biochemical
mechanism by which the introduction of mercury induces hallmark
diagnostic markers indistinguishable from those seen in the
Alzheimer's diseased brain. The authors note that, to date, no other
material or metal tested, including aluminum, has produced even
remotely similar reactions.

The broadcast quality video and animation documenting the biochemical
process of mercury on the nerve cells is available to interested
members of the press through Miss Karen Thomas, Media Relations,
University of Calgary, Faculty of Medicine T: 403-2202945 F: 403-210-
8141 Email: Thomas@ucalgary. The video can be viewed using Quicktime
4.1 at http://commons.ucalgary.ca/mercury/.

The video that accompanies the study entitled, "Retrograde
Degeneration of Neurite Membrane Structural Integrity of Nerve Growth
Cones Following In Vitro Exposure to Mercury" was funded by the
International Academy of Oral Medicine and Toxicology (IAOMT), the
recognized stakeholder experts on Mercury in Canada.

The IAOMT was formed to review, support, and disseminate research on
the suitability of materials and methodologies used in the dental
practice. The IAOMT has funded previous research by Dr. Murray Vimy
on the mercury vapors released from mercury amalgam fillings during
and after chewing, animal research showing pathopysiological damage
to sheep and monkeys from dental amalgam mercury vapor exposure.
Collaborative research with the Calgary authors of this current study
and Dr. Boyd Haley at the University of Kentucky demonstrated
Alzheimer's disease-like brain damage to rats from inhaled mercury
vapor.

Dr. Haley, commenting on the importance of this new
documentation, "Seven of the characteristic markers that we look for
to distinguish Alzheimer's disease can be produced in normal brain
tissues, or cultures of neurons, by the addition of extremely low
levels of mercury1. In addition, research has shown that Alzheimer's
diseased patients have at least 3 times higher blood levels of
mercury than controls. How much more research is necessary before the
appropriate regulatory bodies respond with restrictions on the use of
mercury-leaking dental amalgam fillings?"

1 Alzheimer's diseased brain has been shown to contain dysfunctional
tubulin, creatine kinase and glutamine synthetase,
hyperphosphorylated tau, low levels of reduced glutathione, elevated
amyloid protein and neurofibrillar tangles.


http://www.healthy.net/asp/templates/news.asp?Id=1912

Thomas wrote:

> Hi, I am new to this group - as of today. I removed 4 fillings
> approx. 3 yrs ago. This coming week, I will continue the process,
> removing the remaining mercury.
> Q1: Are there any particular
> supplements I should consider at the day of the removal? Zinc?
> Vitamin C? others?
> Q2: I visited a Dutch kineseologist 3 weeks ago
> (I am from Oslo, Norway). She advised me to remove remaining
> fillings, AND to adhere to "Dr. Lehmann's Amalgam Detox". However,
I
> have not detected anything about this method on the www, and the
> methods and intake differs substantially from Cutler, Mercola, and
> others. It includes a strict program of lymphmyosot (only first 3
> days), chlorella, Zink, Mercurius, etc. etc. incl. a strict
exercise
> regimen in order to sweat out the toxins during the program. There
> are no DMPS, LA incl. However, Cilantro and the Omura fingertip
> massage is involved from week 3 to week 12. So is Amalgam D29 &
> Amalgamsalt D29. Please comment on the Dr. Lehmanns detox, on the
> above or you have earlier knowledge of the program. Thanks.